VUSV

Vanguard Wellington U.S. Value Active ETF

ValueBATSVanguard ETF
$72.92
$0.28 (+0.38%)
Delayed ≥20 min · Aug 14, 2026

Key Statistics

Net Assets (AUM)
$89.70M
Expense Ratio
See prospectus
Previous Close
$72.92
Day Range
- – -
52-Week Range
$58.70 – $73.06
Volume
24.25K
Avg Vol (50D)
-
Beta
0.77

Historical Performance

1M
+6.17%
3M
+9.62%
6M
+12.63%
YTD
+16.41%
1Y
+22.07%
3Y
5Y

Total return including reinvested distributions, from adjusted closing prices.

Price History

Price history is being compiled for this fund.

Top Holdings

Microsoft Corp 2.87%
Amazon.com Inc 2.85%
Alphabet Inc 2.66%
Merck & Co Inc 2.64%
SLB Ltd 2.25%
Chubb Ltd 2.24%
Vanguard Cmt Funds-Vanguard Market Liquidity Fund 2.05%
ASML Holding NV 1.89%
Dover Corp 1.73%
Equinix Inc 1.69%
Morgan Stanley 1.69%
Raymond James Financial Inc 1.66%
T-Mobile US Inc 1.66%
Sempra 1.65%
Valero Energy Corp 1.58%
AstraZeneca PLC 1.56%
M&T Bank Corp 1.55%
Deere & Co 1.55%
Emerson Electric Co 1.54%
Prologis Inc 1.53%
ConocoPhillips 1.53%
Tyson Foods Inc 1.45%
Canadian Natural Resources Ltd 1.37%
Northrop Grumman Corp 1.36%
Reliance Inc 1.36%

Top 25 holdings as of Mar 31, 2026 · source: SEC N-PORT. Full holdings & prospectus →

About VUSV

The Fund employs an active management approach, investing primarily in large- and mid-capitalization companies whose stocks are considered by the Fund’s advisor to be undervalued. Undervalued stocks are generally those that are out of favor with investors and that the advisor believes are trading at prices that are below average in relation to measures such as earnings and book value. Under normal circumstances, the Fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in U.S. securities. For the purposes of the 80% policy, a U.S. security is any security that is issued by a U.S. company.

VUSV News

  • No recent news found for VUSV.

Data for VUSV is aggregated from third-party providers (Tiingo, Nasdaq, Finnhub) and SEC filings, may be delayed at least 20 minutes, and may be incomplete or contain errors. Nothing here is investment advice. Verify with the official prospectus before investing.